FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and medicine, ophthalmology, and may be used for treating corneal diseases and damages. Eye drops contain peptides associated with phospholipids, produced of cod liver, a lubricant, a buffer, a preserving agent, isotonic sodium chloride and water for injections under certain proportions. Eye drops may additionally contain an antioxidant in the amount of 0.01-0.5 wt % specified in a group consisting of sodium metabisulphite, sodium sulphite, sodium thiosulphate or trilon B provided the peptides associated with phospholipids are used in the relation of peptide and phospholipid fractions, wt %: 40-99 peptides and 1-60 phospholipids.
EFFECT: drops exhibit complex anti-inflammatory, stimulating, repair processes and epithelisation.
7 cl, 7 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINE USED FOR PREVENTION AND TREATMENT OF OPHTHALMOLOGIC DISEASES AND METHOD OF ITS PREPARATION | 2010 |
|
RU2442581C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTI-INFLAMMATORY, IMMUNOTROPIC, ANTIALLERGIC AND WOUND HEALING ACTION | 2011 |
|
RU2464993C1 |
| THERAPEUTIC AND PROPHYLACTIC TOOTHPASTE | 2011 |
|
RU2462231C1 |
| GEL POSSESSING ANTI-INFLAMMATORY, IMMUNOTROPIC, ANTIALLERGIC AND WOUND HEALING ACTION | 2011 |
|
RU2457864C1 |
| OPHTHALMIC DROPS "INTERPAN" | 2001 |
|
RU2196588C1 |
| OPHTHALMIC DROP "KARNOSIN" | 2001 |
|
RU2201213C1 |
| EYE DROPS BASED ON COMPOSITION OF PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND METHYLETHYL PYRIDONOL AND TAURINE CONTAINING COMPOSITION OF GROUP B VITAMINS | 2013 |
|
RU2533276C1 |
| EYE DROPS FOR TREATING DRY EYE SYNDROME | 2006 |
|
RU2302231C1 |
| COMBINED OPHTHALMIC AGENT | 2019 |
|
RU2733392C1 |
| OPHTHALMIC DROPS | 2000 |
|
RU2171107C1 |
